NexGen Graphene Polymers Collaborates on New Technology Medical Device Development

Proxy Healthcare and Gino Doctor Sign Agreement for New Technology Medical Device Development

Dr. Jongsoo Kim of NexGen Graphene Polymers, CEO Jinyoung Choi, CEO Youngwook Kim of Proxy Healthcare, CEO Youngsoo Shin of Gino Doctor, and Dr. Kisu Jung of Korea Institute of Industrial Technology (from left) are posing for a commemorative photo after signing the agreement.

[Asia Economy Reporter Kim Cheol-hyun] NexGen Graphene Polymers announced on the 17th that it has signed a business agreement with Proxy Healthcare and Gino Doctor to develop new technology medical devices.

Through this agreement, the development of medical devices combining NexGen Graphene Polymers' carbon material technologies such as graphene, Proxy Healthcare's ProxyWave technology, and Gino Doctor's genomic technology will be promoted.

For the development of new technology medical devices, material technology, applied technology, and clinical capabilities, as well as hospital and overseas networks, are most important. The three companies expect smooth progress in development through this collaboration and technology combination.

NexGen Graphene Polymers will develop materials optimized for ProxyWave applied technology to expand the range of applied products, Proxy Healthcare will advance ProxyWave technology across medical devices, and Gino Doctor will verify and market these in medical institutions and overseas markets.

Choi Jin-young, CEO of NexGen Graphene Polymers, stated, "Through this agreement, the individual technologies and networks of the three companies will collaborate mainly on ProxyWave-related products," adding, "The cooperation fields start with healthcare devices and medical devices but also cover industrial devices and include joint social contribution activities."

This content was produced with the assistance of AI translation services.